Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 3/20 | 0.37 |
| ▸ | CCR8 | P51685 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416550 | 0.88 | DHODH (0.40) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL195314 | 0.88 | DHODH (0.40) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL4149532 | 0.84 | CHRM1 (0.40) | CNR1CNR2NPC1RAB9AMAPK14 | |
| SCHEMBL29416624 | 0.81 | IDO1 (0.38) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL196132 | 0.81 | IDO1 (0.38) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL29416636 | 0.80 | IDO1 (0.38) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL27174182 | 0.80 | IDO1 (0.38) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL230723 | 0.80 | IDO1 (0.38) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL29355401 | 0.80 | IDO1 (0.38) | RIPK1IDO1CNR1CNR2NPC1 | |
| SCHEMBL1385164 | 0.80 | PYGL (0.38) | RIPK1CNR1CNR2MAPK14ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090133318-A1 | Anthranilamide insecticides | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-05-28 | — | — | US | claimed |
| EP-2564706-A1 | Anthranilamide insecticides | E. I. du Pont de Nemours and Company (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20090133318-A1 | Anthranilamide insecticides | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090133318-A1 | Anthranilamide insecticides | C3AR1, C5, C1S | RIPK1 3487/4885IDO1 143/4885CCR8 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.